Counterfeit Medicine (CFM) is defined as a product that is deliberately and fraudulently mislabelled with respect to identity and/or source. According to the World Health Organization, the extent of the CFM problem is not really known, however, the incidences of medicines on sale range from 1% in developed countries to 10-30% in some developing countries. The international concern is the risk CFM poses for public health. There are no reported studies on the nature, and extent of CFM, nor public and pharmacist awareness and attitude towards CFM, in Lebanon.
The study’s objectives were to determine the nature and extent of counterfeit medicines and to assess public and pharmacist awareness, and attitudes towards CFM in Lebanon.
|Date of Award||2015|